Global corporate insolvencies to increase 26% in 2020; Turkey, US, HK to be worst hit
Global corporate insolvencies are likely to increase by 26% in 2020 as the Coronavirus pandemic pushes the world economy into...
InsolvencyT
Registered valuers can’t use limitation, disclaimer clause to escape accountability
The insolvency regulator feels that the professional valuers are using the ‘caveats, limitations and disclaimers’ section of the valuation report...
A creditor’s perspective of disputed claims in insolvency proceedings
By Arvind Mangla Time and again, treatment of disputed claims in Corporate Insolvency Resolution Process (CIRP) had attracted divergent views. ...
Let NCLT first decide if spectrum can be part of insolvency proceeding: SC
The Supreme Court of India has lobbed the ball in the court of the National Company Law Tribunal (NCLT) on...
IBBI moots IT platforms to help insolvency professionals work efficiently
The Insolvency and Bankruptcy Board of India (IBBI) is now planning IT platforms – Platforms for Distressed Assets (PDAs) –...
Home buyers without allotment letter will be treated as financial creditor: NCLT
Home buyers in a real estate project under insolvency will be treated as 'Only Financial Creditor' if they have not...
NCLAT rejects ex-promoter’s appeal against resolution order of Empee Distilleries
The National Company Law Appellate Tribunal (NCLAT) has rejected an appeal against the National Company Law Tribunal’s (NCLT’s) nod to...
Delhi HC stays personal insolvency proceeding against Anil Ambani
The Delhi High Court has stayed personal insolvency proceedings against Anil Ambani started by State Bank of India. The two-judge...
IBBI proposes new measures to make liquidation process faster
The Insolvency and Bankruptcy Board of India (IBBI) has finally shifted its focus to the much ignored area of unending...
NCLT nod for withdrawal of insolvency proceeding against Aspen Bio Pharma
The National Company Law Tribunal (NCLT) has given its approval to withdraw corporate insolvency resolution process (CIRP) against Hyderabad-based pharma...